Back to search

National and Kapodistrian University of Athens

Ανοσοϊστοχημική μελέτη της έκφρασης της κινάσης ERK2 και των πρωτεϊνών των μεταγραφικών παραγόντων ETS-1 και φωσφορυλιωμένης STAT-1 σε διηθητικά καρκινώματα του μαστού

Abstract

dc:description

Introduction: Mitogen-activated protein kinase (MAP kinase) pathways represent a cascade of phosphorylation events, including three pivotal kinases, Raf, MEK and ERK2, which have been implicated in the pathogenesis of cancer. The aim of the present study was to investigate the expression of ERK2 kinase and its target proteins ETS-1 and phosphorylated STAT-1 in invasive breast carcinomas and their correlation with classic clinicopathological parameters and patients’ survival. ETS-1 is a transcription factor, implicated in the regulation of expression of various genes. STAT-1 is the first member of signal transducers and activators of transcription (STATs). Recent studies have demonstrated its apoptotic and anti-proliferative effect in breast cancer experimental models, therefore suggesting a tumor suppressor role.Methods: Immunohistochemistry was performed in paraffin-embedded tissue specimens from 151 invasive breast carcinomas to detect the expression of ERK2, ETS-1 and pSTAT-1 with clinicopathological parameters and patients’ survival. There was insufficient material for the detection of expression of ETS-1 protein for 2 patients. The results were statistically processed using univariate analysis (Pearson’s-chi-square test) and multivariate analysis (logistic regression or Cox proportional hazard regression model). Overall and disease-free survival distribution curves were assessed by Kaplan-Meier test and log rank statistics.Results: ERK2 immunoexpression was detected in the cytoplasm and nucleus ofcancer cells in 37.7% and 19.2% of cases, respectively. Nuclear ERK2 was inversely correlated with ER (p=0.039), whereas cytoplasmic ERK2 was more often expressed in lobular than ductal carcinomas (p=0.026). Nuclear ERK2 expression was found to be an independent prognostic factor of shortened overall survival of patients (p=0.040), while cytoplasmic ERK2 had an independent, favorable effect on both disease-free and overall survival (p<0.0001 and p=0.002, respectively). ETS-1 protein was detected in 77.9% of the cases in the cytoplasm, in 46.3% in the nucleus of the malignant cells, and in stromal fibroblasts as well. Cytoplasmic ETS-1 was inversely correlated with nuclear and histologic grade of the tumor (p=0.004 and 0.033, respectively). Stromal ETS-1 revealed a negative correlation with estrogen receptors (ER) (p=0.003) The univariate statistic analysis showed nuclear ETS-1 to be related to a shortened overall survival of the postmenopausal patients (p=0.032). pSTAT-1 protein was immunodetected in the cytoplasm and nuclei of the malignant cells (11.6% and 8.6% respectively). In premenopausal patients, cytoplasmic pSTAT-1 expression was positively correlated with stage (p=0.014) and ER (p=0.008). Univariate analysis showed that cytoplasmic pSTAT-1, in premenopausal patients, was associated with poor overall survival (p=0.048) and the phenotype of STAT-1/ER or STAT-1/PR co-expression was associated with shorter disease-free survival (p=0.012). On the contrary, in postmenopausal patients no association with clinicopathologic parameters and survival was observed, expect for the relation of pSTAT-1/ER or STAT-1/PR co-expression with longer disease-free survival (p=0.034).Conclusion: Τhe present study for the first time indicates that the ERK2 kinase, ETS-1 protein and pSTAT-1 protein signaling pathway has a distinctive role in women with breast cancer. Specifically, compartmentalization of ERK2, as revealed by its immunodetection in the cytoplasm and nuclei of breast cancer cells, reflects a different effect on patient survival, with nuclear ERK2 being prognostic of a shortened overall survival and cytoplasmic localization being an independent favorable prognosticator of both disease-free and overall survival. In addition, ETS-1 seems to be related to a different tumor phenotype according to its topographic distribution, with nuclear localization being associated with decreased cumulative survival in postmenopausal women. Furthermore, our results suggest that pSTAT-1 is related to tumor progression in premenopausal patients through the advanced stage and decreased cumulative survival. Hence, further investigation of the ERK2 kinase, ETS-1 protein and pSTAT-1 protein signaling pathway might be crucial for exploring new therapy targets.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Rafailidis, Petros
  • Ραφαηλίδης, Πέτρος

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/41838

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Rafailidis, Petros; Ραφαηλίδης, Πέτρος. Ανοσοϊστοχημική μελέτη της έκφρασης της κινάσης ERK2 και των πρωτεϊνών των μεταγραφικών παραγόντων ETS-1 και φωσφορυλιωμένης STAT-1 σε διηθητικά καρκινώματα του μαστού. National and Kapodistrian University of Athens, 2014. http://hdl.handle.net/10442/hedi/41838